Histopathologic features of ovaries at increased risk for carcinoma: A case-control analysis

International Journal of Gynecological Pathology

Volumn 18, Issue 2, 1999, Pages 151-157

  Sherman, Mark E ^a,b   Lee, Jennifer S ^a,c   Burks, R Tucker ^d   Struewing, Jeffery P ^a   Kurman, Robert J ^b   Hartge, Patricia ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinogenesis; Carcinoma; Epidemiology; Ovary; Pathogenesis; Precursor

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; OVARIECTOMY; OVARY CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033038355     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199904000-00009     Document Type: Article

References (22)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;65:5-27.
2. Scully RE. Ovary. In: Henson DE, Albores-Saavedra J, eds. Pathology of Incipient Neoplasia, 2nd Ed. Philadelphia: W.B. Saunders, Harcourt Brace Jovanovich, 1993;283-300.
3. Boice JD, Jr, Lubin JH, Paston DL. EPITOME: Epidemiologic Analysis with a personal computer. Bethesda, MD: National Institutes of Health, 1996. NIH publication 96-3180.
4. Pike MC. Age-related factors in cancers of the breast, ovary, and endometrium. J Chronic Dis 1987;40(Suppl 2):59S-69S.
5. Westhoff C, Murphy P, Heller D, Halim A. Is ovarian cancer associated with an increased frequency of germinal inclusion cysts? Am J Epidemiol 1993;138:90-3.
6. Salazaar H, Godwin AK, Daly MB, et al. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst 1996;88:1810-20.
7. Afify AM, Bielat KL, Eltabbakh GH, Piver MS, Patterson JM, Werness BA. Characteristics of ovaries prophylactically removed from women with a family history of ovarian cancer (Abstract). Mod Pathol 1998;11:100A.
8. Resta L, Russo S, Colucci GA, Prat J. Morphologic precursors of ovarian epithelial tumors. Obstet Gynecol 1993;82:181-6.
9. Mittal KR, Zeleniuch-Jacquotte A, Cooper JL, Demopoulos RI. Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. Int J Gynecol Pathol 1993;12:59-63.
10. Gusberg SB, Deligdisch L. Ovarian dysplasia: a study of identical twins. Cancer 1984;54:1-4.
11. Plaxe SC, Deligdisch L, Dottino PR, Cohen CJ. Ovarian intraepithelial neoplasia demonstrated in patients with Stage I ovarian carcinoma. Gynecol Oncol 1990;38:367-72.
12. Deligdisch L, Gil J. Characterization of ovarian dysplasia by interactive morphometry. Cancer 1989;63:748-55.
13. Deligdisch L, Heller D, Gil J. Interactive morphometry of normal and hyperplastic peritoneal mesothelial cells and dysplastic and malignant ovarian cells. Hum Pathol 1990;21:218-22.
14. Deligdisch L, Miranda C, Barba J, Gil J. Ovarian dysplasia: nuclear texture analysis. Cancer 1993;72:3253-7.
15. Gil J, Deligdisch L. Interactive morphometric procedures and statistical analysis in the diagnosis of ovarian dysplasia and carcinoma. Pathol Res Pract 1989;185:680-5.
16. Deligdisch L, Einstein AJ, Guera D, Gil J. Ovarian dysplasia in epithelial inclusion cysts: a morphometric approach using neural networks. Cancer 1995;76:1027-34.
17. Blaustein A, Kaganowicz A, Wells J. Tumor markers in inclusion cysts of the ovary. Cancer 1982;49:722-6.
18. Wang D, Konishi I, Koshiyama M, et al. Immunohistochemical localization of c-erB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumors of the ovary. Virchows Archiv A Pathol Anat 1992;421:393-100.
19. van Niekerk CC, Boerman OC, Ramaekers FCS, Poels LG. Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas. Am J Pathol 1991;138:455-63.
20. Auersperg N, Maines-Bandiera S, Booth JH, Lynch HT, Godwin AK, Hamilton TC. Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history in ovarian cancer. Am J Obstet Gynecol 1995;173:558-65.
21. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.
22. Second cancer following cancer of the female genital system in Connecticut, 1935-82. In: Kleinerman RA, Liebermann JV, Li FP, eds. National Cancer Institute Monograph number 68. NIH publication No. 85-2714. Multiple Primary Cancers in Connecticut and Denmark. Bethesda, MD: US Department of HHS, Public Health Service, NIH, NCI, 1985:113-38.